Skip to content
AI IntelligenceJun 19, 2026Secondary Market
Article

RXRX

Recursion Pharmaceuticals filed an 8-K regarding the submission of matters to a vote of security holders. This is a routine disclosure following the annual meeting.

AI-generated: summaries written by AI from the linked sources. How we use AI

AI-generatedSource: SEC EDGAR
01

Source Brief

Recursion Pharmaceuticals filed an 8-K regarding the submission of matters to a vote of security holders. This is a routine disclosure following the annual meeting.